Skip to main content
. 2021 Oct 12;2021(10):CD011589. doi: 10.1002/14651858.CD011589.pub2

NCT02949167.

Study name MyHealth: Follow‐up after breast cancer treatment
Methods Randomised trial, Denmark
Participants 494 primary BC patients will be recruited from the Departments of Oncology at Naestved and Roskilde Hospital. Inclusion criteria: Complete remission following primary treatment for loco‐regional BC (stage I‐II) ‐ No confirmed genetic predisposition to BC
Female gender
Performance status ≤3
Read, understand and speak Danish
No severe cognitive problems
No severe psychiatric disease requiring treatment or any substance abuse.
Interventions The MyHealth intervention is a nurse‐led individually tailored symptom management program, focused on patient education and regularly collection of Patient Reported Outcomes (PRO) subsequently evaluated by specialist nurses and navigation to health care service. The nurse will meet with the patient on three‐five planned appointments focused on adjustment of life after breast cancer treatment including information on symptoms of relapse or late effects and how to react on these. Close relatives are invited if patients accept. Patients will report PRO´s on symptoms of recurrence and late effects every three months during the first year and thereafter every six months.The appointments with the nurse are finalized within 3‐6 month and patients will be followed with PRO for three years.
Outcomes Primary outcome: Changes in breast cancer specific symptom burden (TOI‐PFB) [ Time Frame: at inclusion, 6 months,12 months, 24 months, 36 months and 60 months]
Starting date November 2016
Contact information Christoffer Johansen, The Cancer Society Research Center, Survivorship
Notes